Paolo Bettica News Today : Breaking News, Live Updates & Top Stories | Vimarsana

FDA Approves Duvystat, New Oral Treatment for Duchenne Muscular Dystrophy (DMD)

FDA Approves Duvystat, New Oral Treatment for Duchenne Muscular Dystrophy (DMD)
plos.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from plos.org Daily Mail and Mail on Sunday newspapers.

San diegoUnited statesPaolo betticaBarry byrneMuscular dystrophy associationUniversity of floridaPowell gene therapy centerItalfarmaco groupNorth americaPier lorenzo puriLancet neurologyScant proteinChief medical officerBarry byrne chief medical advisor

FDA approves Duvyzat for treatment of Duchenne muscular dystrophy

FDA approves Duvyzat for treatment of Duchenne muscular dystrophy
healio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healio.com Daily Mail and Mail on Sunday newspapers.

United statesShenaz baghaPaolo betticaBysara kellnerItalfarmaco group

FDA Extends Review Time for Investigational Duchenne Agent Givinostat

Givinostat, a histone deacetylase inhibitor from Italfarmaco, was supported by data from the phase 3 EPIDYS study, a randomized, double-blind, placebo-controlled, multicenter trial investigating the agent vs placebo.

Paolo betticaItalfarmaco paolo betticaCraig mcdonaldDepartment of pediatricsUc davis healthUc davis health craig mcdonaldPrescription drug user fee actNorth star ambulatory assessmentPhysical medicineHistone deacetylase

Italfarmaco Group Receives EMA Validation of Marketing Authorization Application for Givinostat in Duchenne Muscular Dystrophy

Italfarmaco Group Receives EMA Validation of Marketing Authorization Application for Givinostat in Duchenne Muscular Dystrophy
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Baden wübergSan diegoUnited statesPaolo betticaGretchen schweitzerCarlos barallobreTrophic communicationsSanta lucia foundationItalfarmaco groupEuropean medicine agencyDrug administrationItalfarmaco group new drug applicationMarketing authorization applicationDuchenne muscular dystrophyNew drug applicationChief medical officer

Italfarmaco Group Completes FDA Submission of New Drug Application for Givinostat in Duchenne Muscular Dystrophy and Receives Priority Review

Italfarmaco Group Completes FDA Submission of New Drug Application for Givinostat in Duchenne Muscular Dystrophy and Receives Priority Review
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

San diegoUnited statesCarlos barallobrePaolo betticaGretchen schweitzerTrophic communicationsSanta lucia foundationItalfarmaco groupDrug administrationResearch rowNew drug applicationDuchenne muscular dystrophyPrescription drug user fee actChief medical officerParent project muscular dystrophyLorenzo puri